Rap1 is a small GTPase implicated in cell proliferation and dierentiation. The mechanisms how endogenous Rap1 is activated by many mitogenic stimuli including the neuropeptide bombesin remained unclear. Here we analyse which signaling pathways are necessary for Rap1 activation. Bombesin-mediated Rap1 activation in Swiss 3T3 and primary mouse embryo ®broblasts requires signaling components similar to those being essential for complex formation between p130Cas and Crk adapter proteins. The Crk/CRKL-binding region of the Rap1-speci®c exchange factor C3G (CBR) inhibits the bombesin-stimulated Rap1 activity in transfected Swiss 3T3 cells. Further characterization in COS cells showed that the CBR or a c-Crk I SH3 mutant speci®cally reduces both the basal as well as the stimulated Rap1 activity in a dose-dependent manner, whereas Ras is not aected. The CBR is complexed with endogenous c-Crk II and CRKL and blocks the protein association with catalytically active C3G. Such suppressors of Crk signaling do not aect Erk-phosphorylation induced by bombesin. Embryonic ®broblasts from b-raf knockout mice showed a bombesin-inducible Erk-phosphorylation, providing evidence that B-Raf does not link Rap1 to Erk-activation in bombesin-stimulated ®broblasts. We conclude that cellular Crk/CRKL complexes, recruited to upstream signaling components, contribute to basal and bombesin-induced Rap1 activity, which is independent from the Ras-Raf-Erk pathway under these circumstances. Oncogene (2000) 19, 6361 ± 6368.
Introduction
Rap1 is a small GTPase involved in cell proliferation, dierentiation and morphogenesis. Similar to the homologous Ras proteins, it serves as a molecular switch, cycling between the GDP-loaded, inactive state and the GTP-loaded, active state (reviewed in Bos, 1998) . The GTP-loading of Rap1 is regulated by GTPase activating proteins (GAPs) and guaninenucleotide exchange factors (GEFs). Several GEFs of Rap1 are known, including C3G, a CrkSH3 domainbinding GEF, and the recently cloned Epac/cAMP-GEF I, Epac2/cAMP-GEF II, and CalDAG-GEF I, which are directly activated by the second messenger molecules cyclic AMP, Ca 2+ or diacylglycerol (DAG) (de Rooij et al., 1998; Kawasaki et al., 1998a,b; Knudsen et al., 1994) . Rap1 was initially identi®ed as a Ras-related protein that reverts transformation by Ki-Ras (Kitayama et al., 1989; Pizon et al., 1988) . In contrast, Rap1 itself was shown to induce DNA synthesis, cellular transformation and tumor formation in nude mice (Altschuler and Ribeiro-Neto, 1998; Yoshida et al., 1992) . In Drosophila, deletion of both rap1 alleles is lethal, and a reduced level of Rap1 results in impaired development of the eyes and the ovaries, but also in developmental defects of the embryos, independently of Ras signaling pathways (Asha et al., 1999; Hariharan et al., 1991) .
Rap1 and Ras share high homology in their eector domains. Many target proteins can bind to Ras as well as to Rap1 (Bos, 1998) . However, dierences in the anities of potential eectors exist, and Rap1-speci®c downstream targets like Krit-1 have been characterized (Herrmann et al., 1996; Serebriiskii et al., 1997 Serebriiskii et al., , 1999 . Modulation of the mitogenic cascade is believed to be one function of Rap1. Activation of Rap1 in nonproductively stimulated T lymphocytes leads to binding and inactivation of the c-Raf-1 kinase, thereby inducing the non-proliferative anergic state (Boussiotis et al., 1997) . Other studies with PC12 cells stimulated by NGF suggest that GTP-loaded Rap1 binds the BRaf isozyme which is activated and mediates sustained Erk activation and dierentiation of these cells (York et al., 1998) . In ®broblasts, we and others have recently shown that Rap1 is activated by many mitogenic stimuli, including cell adhesion, TPA, lysophosphatidic acid (LPA) and neuropeptides like bombesin (Posern et al., 1998a; Tsukamoto et al., 1999; Zwartkruis et al., 1998) . However, stimulation with LPA or neuropeptides failed to aect the kinase activity of either c-Raf-1 or B-Raf (Mitchell et al., 1995; Posern et al., 1998a; Seuerlein et al., 1996; Zwartkruis et al., 1998) .
Bombesin is a mitogenic neuropeptide which was originally isolated from frog skin. The mammalian homolog is the gastrin-releasing peptide, GRP. It is implicated in neoplastic growth, especially as an autocrine growth factor in small cell lung cancer (Cuttitta et al., 1985) and other malignancies. After binding to its cognate receptors, bombesin activates heterotrimeric G-proteins of the G q family. This results in activation of phospholipase C (PLC), which in turn leads to activation of protein kinase C (PKC) and the release of Ca 2+ from intracellular stores (reviewed in Rozengurt, 1998) . Beside this, a common pathway has been described which involves the small GTPase Rho, the focal adhesion kinase FAK and Src family members (Rozengurt, 1998; Schlaepfer and Hunter, 1998) . The kinases recruit the multi-site docking protein p130Cas and phosphorylate tyrosine residues in its substrate region, which contains no less than 15 YxxP motifs (Nakamoto et al., 1996) . Phosphorylation of these motifs creates high anity binding sites for the SH2 domains of Crk and CRKL. p130Cas rapidly associates with Crk adapters following treatment with bombesin (Casamassima and Rozengurt, 1997) . This pathway is stimulated by many mitogenic agents, including other neuropetides, TPA and LPA (Rozengurt, 1998) . It requires an intact actin cytoskeleton, but has been shown to be independent of Ca 2+ and PI3K in Swiss 3T3 cells (Casamassima and Rozengurt, 1997) .
The small adapter proteins of the Crk family were identi®ed as the cellular homologs of the v-Crk oncogene product. They consist almost entirely of SH2 and SH3 domains (reviewed in Feller et al., 1998) . Crk adapters connect signaling components by binding to tyrosine phosphorylated proteins via the SH2 domain and proline-rich proteins via the ®rst SH3 domain. Phage display library screens and the analysis of CrkSH3(1) binding motifs demonstrated a strong preference for PxxPxK motifs, four of which are present in C3G, a major CrkSH3(1) binding protein (Knudsen et al., 1994; Sparks et al., 1996) .
Although C3G has been shown to selectively activate Rap1 (Gotoh et al., 1995) , a negative role of Crk-C3G complexes by sequestering the GEF following extracellular stimulation would also theoretically be possible. Therefore, we used speci®c inhibitory constructs and showed that Crk/CRKL SH3-mediated signaling complexes, most likely with C3G, are acting positively on the levels of GTP-loaded Rap1. The requirements for Rap1 activation and p130Cas phosphorylation by bombesin are similar in some, but not all, ®broblast cells. Furthermore, modulation of Rap1 activity or CBR expression did not aect bombesin-induced Erkphosphorylation, and Erk was activated by bombesin independently from B-Raf.
Results

Requirements for Rap1 activation in different fibroblasts
It was previously shown that the small GTPase Rap1 is activated following various mitogenic stimuli (Posern et al., 1998a; Zwartkruis et al., 1998) . Many of these stimuli, including the neuropeptide growth factor bombesin, are known to induce tyrosine phosphorylation of p130Cas and subsequent complex formation with the small adapter proteins of the Crk family (Casamassima and Rozengurt, 1997) . Since c-Crk and CRKL bind via their ®rst SH3 domains to the Rap1-speci®c GEF C3G, they possibly regulate the activation state of Rap1. Association of p130Cas with Crk adapters requires an intact actin cytoskeleton, but is independent of PKC or intracellular Ca 2+ in bombesinstimulated Swiss 3T3 ®broblasts (Casamassima and Rozengurt, 1997) . To test if the Rap1 activation requires similar upstream signaling components, speci®c inhibitors were used. Bombesin-induced Rap1 activation in Swiss 3T3 was indeed strongly inhibited by cytochalasin D, which depolymerizes F-actin and disrupts the cytoskeleton (Figure 1a) . The PLC inhibitor U 73122 and the cell-penetrating calciumchelating agent BAPTA-AM did not aect Rap1 activation in Swiss 3T3. In contrast, results from NIH3T3 cells pretreated with cytochalasin D showed no inhibition of bombesin-induced Rap1 activation (Posern et al., 1998a) . Rather, Rap1 induction by bombesin was dependent on PLC and Ca 2+ ( Figure  1b) . Thus, unexpected dierences in the requirements for upstream signaling were found (summarized in Figure 1b ). To further investigate bombesin signaling pathways in ®broblasts, primary non-immortalized mouse embryo ®broblasts (MEFs) were analysed, which should resemble more closely the in vivo situation. The MEFs showed an actin-dependent and Ca 2+ -independent Rap1 activation by bombesin, similar to the situation in Swiss 3T3 cells (Figure 1b) . The ®ndings were supported by the results obtained with the Ca 2+ -Ionophore A23187, which does not activate Rap1 in MEFs, although it is a sucient activator in NIH3T3 cells. Thus, the requirements for bombesininduced Rap1 activation match at least in some cells the known requirements for Cas-Crk complex formation.
Since bombesin activates a variety of signal transducers and many of these can also activate Rap1 in some systems, other inhibitors were also tested. Two dierent inhibitors for PKC inhibit the TPA-induced Rap1 activation in all three mouse ®broblasts, yet they do not aect the bombesin-induced Rap1 activity. H 89 and LY 294002, inhibitors speci®c for PKA and phosphatidylinositol 3-kinase, respectively, did not reduce Rap1 activation, suggesting that these two components are not involved in this particular signaling system.
Inhibition of Rap1 activity by the dominant negative C3G-CBR fragment
To analyse whether the activation of Rap1 really involves Crk/CRKL signaling pathways, as suggested from the inhibitor studies, dominant negative constructs speci®c for Crk were used. The Crk-binding region of C3G (CBR) is expected to act as a suppressor of Crk signaling by blocking the protein interactions mediated via the ®rst SH3 domain of Crk adapters (York et al., 1998) . This block is likely to be very speci®c, because C3G-derived motifs bind to c-Crk and CRKL with an unusually high selectivity (Posern et al., 1998b) . Cotransfection of hemagglutinin-tagged Rap1 (de Rooij et al., 1998) allowed to analyse its GTP loading speci®cally in the transfected cells. HA-tagged Rap1 was indeed activated by bombesin in Swiss 3T3 cells transfected with the Lipofectamin reagent ( Figure  2a) . Cotransfection of the CBR fragment, but not of the vector alone, inhibited both the basal and the bombesin-induced activity of HA-Rap1.
Since Swiss 3T3 are dicult to transfect, and high expression rates of HA-Rap1 are required for the biochemical pulldown assay, COS-7 cells were used for further characterization. Also in these cells, HA-tagged Rap1 was activated by bombesin, LPA and vanadate. The tyrosine phosphatase inhibitor vanadate is known to activate mitogenic pathways and leads e.g. to hyperphosphorylation of p130Cas (Ru et al., 1997) . Again, cotransfection of the CBR fragment inhibited both the basal and the induced activity of HA-Rap1 ( Figure 2b ). This eect was concentration-dependent. Since vanadate turned out to be a robust activator of Rap1, it was used as the stimulus for a titration experiment. Increasing amounts of plasmid encoding CBR lead to increasing expression of the CBR fragment, accompanied with decreasing activities of HA-Rap1. Extended expression of the CBR fragment leads to a reduction of the coexpressed HA-Rap1, due to unknown reasons. However, densitometric analysis and comparison of the expression levels with the activity levels showed a strong dose-dependent reduction of HA-Rap1 activation ( Figure 2c ).
To acertain the speci®city of the observed CBR eect, several control experiments were performed. A polyclonal antiserum which recognize both endogenous C3G and the transfected CBR-fragment was used for immunoprecipitations. Endogenous c-Crk II precipitated with the CBR-fragment, demonstrating that indeed Crk adapter proteins are bound to the transiently expressed CBR (Figure 3a) . To show that association with catalytically active, endogenous C3G is thereby impaired, the presence of C3G in Crk or CRKL immunoprecipates was analysed. We did not ®nd C3G in Crk immunoprecipitates, probably because the monoclonal antibody could not recognize complexed c-Crk. However, endogenous C3G eciently coprecipitated with CRKL in control-transfected cell lysates using a polyclonal anti-CRKL antibody. This is severely impaired in CBR-transfected cells (Figure 3b) . Instead, the CBR-fragment associates with endogenous CRKL. The results indicate that the CBR fragment indeed inhibits Crk/CRKL-mediated signal transduction by blocking the SH3(1)-domains of Crk adapter proteins, thereby leading to the reduction of Rap1 activity.
Specificity of the CBR effect
To further investigate the consequences of CBR expression, a possible eect on GTP-loading of Ras was determined. In contrast to HA-Rap1, cotransfected HA-tagged Ras did not show an alteration of its basal activity (Figure 4a ). CBR expression also did not aect the activity of endogenous Ras (not shown), indicating that Crk-C3G signaling does not have a strong in¯uence on Ras. The known interaction between the Figure 1 Pretreatment with speci®c inhibitors dierentially in¯uences Rap1 activation in ®broblasts. (a) Rap1 activity after bombesin or TPA stimulation of Swiss 3T3 ®broblasts following pretreatment with inhibitory compounds. Cells were grown to con¯uence, starved with 0.5% FCS overnight and pretreated with speci®c inhibitors for the times and concentrations as indicated in (b). Subsequently, the cells were not stimulated (w/o), stimulated with TPA (100 ng/ml, 10 min) or bombesin (BN; 120 nM, 3 min), and lysed in MLB buer. Rap1 activity was analysed by subjecting 700 mg of protein lysate to precipitation with 20 mg GSTRalGDS-RBD fusion protein, coupled to glutathione beads. Subsequently, washed precipitates were blotted with a monoclonal antibody against Rap1 (upper panel). As a control, expression levels of Rap1 are shown in the corresponding total cell lysates (lower panel). (b) Summary of the activation of endogenous Rap1 in dierent mouse ®broblasts following pretreatment with the indicated inhibitors. Cells treated with the Calcium-Ionophore A 23187 were not stimulated with TPA or bombesin. Asterisks mark the most important dierences which separate NIH3T3 cells from non-immortalized, primary mouse embryo ®broblasts and Swiss 3T3 cells. +: full activation of Rap1; 7: no activation of Rap1; +/7: partial inhibiton of Rap1 activation; n.d.: not determined with empty vector, were cotransfected with HA-Rap1, as indicated. After stimulation with vanadate, the activity of HARap1 was determined as before. Because the expression levels of HA-Rap1 decrease slightly with expression of CBR, blots were densitometrically analysed and the ratio was determined. The relative activation and its inhibition by CBR in the above experiment is shown in the bar diagram CrkSH3(1) domain and the Ras exchange factor SoS, which is presumably also abolished following CBR expression, apparently does not play an important role, which is in accordance with the low anity of SoSderived peptides for the CrkSH3(1) domain (Posern et al., 1998b) .
To exclude that the eect of the CBR fragment is explained by overexpression artefacts, e.g. nonspeci®c binding to HA-tagged Rap1 or endogenous C3G, several immunoprecipitation experiments were done. Endogenous C3G was precipitated by an antibody which recognized the C-terminal end of C3G, but not the CBR fragment. No coprecipitation of the CBR fragment with full length C3G was observed ( Figure  4b ). CBR could also not be detected in HA-Rap1 precipitates (Figure 4c ). It is thus concluded that the observed eects of CBR expression are unlikely to be simply overexpression artefacts, but are evoked by speci®cally blocking the Crk/CRKL-Rap1 pathway.
The importance of a Crk-dependent signaling pathway in the activation of Rap1 was further supported by the use of c-Crk I with a mutated SH3 domain (K170) (Tanaka et al., 1995) . This construct was chosen because it does not contain the regulatory tyrosine phosphorylation site (Y221) nor the mutations of CT-10 derived v-Crk and is expressed equally well than the wildtype c-Crk I. Because the c-Crk I SH3-mutant lacks a functional SH3 domain but contains the SH2 domain, the construct putatively occupies and blocks CrkSH2-binding sites on phosphoproteins like p130Cas. Indeed, cotransfected c-Crk I SH3 mutant, but not the wildtype c-Crk I, led to an inhibition of HA-Rap1 activity to an extent similar to the CBR construct (Figure 5a) , thereby emphasizing the importance of Crk/CRKL-complex formation via both the SH2 and SH3 domains.
If the CBR construct does not aect Rap1 directly, one expects that alternative modes of activating Rap1 are not in¯uenced by CBR or the c-Crk I SH3 mutant. Epac, recently cloned as a Rap1-speci®c GEF activated by cAMP, and a constitutively active mutant (Epac DcAMP) (de Rooij et al., 1998), were cotransfected with HA-tagged Rap1 into COS-7 cells. As expected, HA-Rap1 was strongly activated. This activation was not in¯uenced by cotransfection of CBR or the c-Crk I SH3 mutant (Figure 5b ). This de®nes Epac and the recruitment of Crk/CRKL-C3G-complexes as two independent pathways, both ®nally resulting in Rap1 activation.
Relationship between Rap1 activity and B-Raf/MEK/Erk
We and others have recently shown that bombesin activates the MAP kinase Erk, but not Ras, c-Raf-1 or B-Raf (Mitchell et al., 1995; Posern et al., 1998a; Seuerlein et al., 1996; Zwartkruis et al., 1998) . In contrast, for PC12 cells stimulated with NGF a pathway was suggested leading from Rap1 via B-Raf to Erk activation (York et al., 1998) . If Rap1 is also involved in Erk activation by bombesin, the expression of CBR or c-Crk I SH3 mutant would be expected to in¯uence Erk activity by inhibiting Rap1. However, no changes in both the basal and the bombesin-induced Erk activation was observed, as determined with activation-speci®c phospho-Erk antibodies ( Figure  5c ). Expression of the wildtype c-Crk I did not aect Erk activity as well. Furthermore, Epac and, in particular, Epac DcAMP, which strongly activates Rap1, did not lead to a signi®cant increase of Erk activity.
Previously we reported that the kinase activity of BRaf in bombesin-stimulated NIH3T3 ®broblasts is not increased (Posern et al., 1998a) . However, NIH3T3 cells have dierent bombesin signaling properties than primary MEFs, as shown in Figure 1b . To test if B-Raf is indeed not needed for bombesin stimulated Erk activity, embryo ®broblasts of b-raf de®cient mice (Wojnowski et al., 1997) were analysed. Bombesin and TPA activated Erk in both b-raf 7/7 and b-raf +/+ cells to a similar extent, although the bombesin-induced Erk-activity was much weaker than the positive control stimulated with TPA (Figure 6a ). Rap1 activation was not aected in b-raf 7/7 cells. It is concluded that B-Raf does not link Rap1 to Erk activation after bombesin stimulation of these ®broblasts. Rather, Erk activation seems to be independent from Rap1 activity. Pretreatment with cytochalasin D, which abolishes Rap1 activity in primary MEFs (Figure 1b) , did not signi®cantly reduce Erk activation by bombesin ( Figure  6b ). The activation of Erk was found to be transient, declining already after 3 min, whereas the Rap1 activation is maintained for more than 90 min (Posern et al., 1998a and data not shown).
Because neither B-Raf nor c-Raf-1 are required for bombesin-induced Erk activation, it was investigated whether MEKs, the kinases directly upstream of Erk, (Figure 6b ). Taken together, the results suggest that a MEK activator other than B-Raf or cRaf-1 mediate bombesin-induced Erk activation, using a so far unknown signaling pathway. Since Rap1 is not involved in the modulation of Erk activity, the intriguing question remains which cellular functions are controlled by GTP-loaded Rap1.
Discussion
We have shown here that Rap1 activation in bombesin stimulated ®broblasts is mediated by complex formation of endogenous Crk or CRKL adapter proteins. Blocking the interaction of Crk/CRKL with C3G or their recruitment to putative upstream phosphoproteins by expressing dominant negative constructs impairs Rap1 activation by certain stimuli in Swiss 3T3 and COS cells. Thus, it is the most likely explanation that C3G is mediating the Crk-dependent activation of Rap1, although we cannot rule out the possibility that other proteins capable of binding the CrkSH3(1) domain are involved. Since the CBR constructs also reduced the nonstimulated activity, the Crk-C3G-Rap1 pathway seems to contribute to the basal level of GTP loading on Rap1 as well. However, other means of activating Rap1, i.e. by Epac, are not aected, demonstrating the speci®city of the CBR construct and proving it as a useful tool for analysing the function of Crk adapters. Notably, activation of Rap1 by other receptors or in distinct cell systems may not require Crk signaling pathways, but may be dependent on the action of other Rap1-GEFs like Epac.
The results obtained by using speci®c inhibitors for potential upstream signaling components of Rap1 suggest that recruitment of Crk-C3G complexes to the multi-site docking protein p130Cas is involved in the activation of Rap1. The requirements for Rap1 activation in Swiss 3T3 cells by bombesin are identical to those known for phosphorylation of p130Cas and subsequent Crk association (Casamassima and Rozengurt, 1997): dependence on an intact actin cytoskeleton, but independence from PLC, PKC or Ca 2+ ( Figure 1a) . Furthermore, PI3K and PKA do not play an important role in activating Rap1. Several conclusions can be drawn from the inhibitor studies. First, an essential role for PKA in activating Rap1 could be excluded. Second, TPA-mediated activation of Rap1 is dependent on PKC, but independent from Ca 2+ , arguing against an important role of CalDAG-GEFs (which would be directly activated by TPA). Third, it is unlikely that Epac/cAMP-GEFs contribute strongly to the rapidly observed Rap1 activation, because the adenylate cyclase is not an immediate target of (Rozengurt, 1998) . cAMP is only indirectly generated following an autocrine loop involving PLA 2 , arachidonic acid and G s -coupled receptors, which is unlikely to be of relevance for the very early eects reported here. The distinct signaling mechanisms in NIH3T3 cells might be explained by known dierences between NIH3T3 and Swiss 3T3 cells or primary MEFs, i.e. with regard to the cytoskeletal organization (Olson et al., 1998) . The results would also be compatible with the assumption that a Ca 2+ -dependent tyrosine kinase like Pyk2 (syn. RAFTK/CAKb/FAK2) took over the function of the actin-dependent FAK. However, the FAK-related kinase Pyk2, which also induces phosphorylation of p130Cas and association with Crk, is mainly expressed in neuronal and hematopoetic tissues and is absent in mouse embryo ®broblasts (Blaukat et al., 1999; Sasaki et al., 1995) . Further studies are needed to fully clearify the distinct signaling systems between the widely used mouse ®broblast cell lines Swiss 3T3 and NIH3T3.
Materials and methods
Materials and constructs
Bombesin, cytochalasin D, A 23187 and lysophosphatidic acid (LPA) were purchased from Sigma. U 73122, BAPTA-AM, GF 109203, Ro 318220, H 89, LY 294002, PD 98059, UO 126 and TPA were from Calbiochem. GlutathioneSepharose 4B, Protein A-Sepharose and Protein G-Sepharose were obtained from Amersham-Pharmacia, as well as blotting membranes and ECL detection reagents.
Eucaryotic expression vectors pMT2-HA-Rap1, pMT2-HA-Ras, pMT2-HA-Epac (wildtype and DcAMP) as well as the bacterial expression vector pGEX-RalGDS-RBD were kindly provided by F Zwartkruis and JL Bos (Utrecht, The Netherlands) (de Rooij et al., 1998) . pcDNA3-CBR was a generous gift from P Stork (Portland, OR, USA) (York et al., 1998) . pEBB-c-Crk I and pEBB-c-Crk I SH3mut.(K170) were kindly provided by B Mayer (Boston, MA, USA) (Tanaka et al., 1995) . Both the endogenous C3G protein as well as the transiently expressed CBR fragment were recognized by a rabbit polyclonal antiserum previously generated against the Crk-binding motifs of C3G (#RF45) (Knudsen et al., 1994) . For immunoprecitation of C3G only, a commercially available antibody was used (Santa Cruz sc-869). Other antibodies used were: anti-hemagglutinin (12CA5), anti-Crk (Transduction Laboratories, C 12620), anti-Rap1 (Transduction Laboratories, R 22020), anti-CRKL (Santa Cruz, sc-319), anti-Erk1 (Santa Cruz, sc-93), anti-Erk2 (Santa Cruz, sc-154), anti-phospho-Erk (NEB #9101).
Cell culture and transfections
NIH3T3, COS-7 and Swiss 3T3 were maintained in DMEM supplemented with 10% FCS and antibiotics. Primary mouse embryo ®broblasts (MEFs) were isolated from 14-days old embryos of 129/Ola mice and were grown in DMEM with 15% FCS, 1 mM sodium pyruvate. The b-raf de®cient cells were isolated from b-raf knockout mice according to standard procedures (Wojnowski et al., 1997) . For transfection experiments Swiss 3T3 cells were seeded at 1610 6 cells per 10 cm 1 plate, transfected for 4 h using 40 ml of Lipofectamin reagent (Gibco BRL) and starved afterwards with 0.5% FCS for 20 h before bombesin stimulation. COS-7 cells were seeded at 3610 5 cells per 10 cm 1 plate, transfected for 6 h using the calcium-phosphate method and analysed 30 ± 36 h after removal of the precipitates.
GTPase activation assays and coprecipitations
GTPase activity was determined in cells with strictly controlled plating density (for endogenous Rap1 3610 6 cells per 10 cm 1 plate), because this strongly aects basal Rap1 activity (Posern et al., 1998a) . Brie¯y, cells were lysed in Mg 2+ -containing lysis buer (MLB; 25 mM HEPES pH 7.5, 150 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA, 10% glycerol, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM sodium vanadate, 10 mg/ml aprotinin, 0.5 mg/ml leupeptin). ) were starved overnight in 0.5% FCS and stimulated with bombesin (BN) or TPA. Activation of endogenous Rap1 and Erk was determined simultanously in MLB lysates using the described anity precipitation method or activation-speci®c anti-phospho-Erk antibodies, respectively. (b) Erk phosphorylation requires MEK but not an intact actin cytoskeleton in primary MEFs. Non-immortalized mouse embryo ®broblasts were pretreated with DMSO control, cytochalasin D (Cyto D; 1 mM, 45 min) or the two unrelated MEK inhibitors PD 98059 (10 mM, 45 min) and UO 126 (1 mM, 45 min). Subsequently, cells were stimulated with bombesin (BN; 120 nM, 3 min) or TPA (100 ng/ml, 10 min) as a control and lysed in RIPA. Erk activity was determined by Western blotting with anti-phospho-Erk antibodies and compared to Erk 1 expression. w/o: without stimulation 400 ± 700 mg of protein lysates were subjected to precipitation for 1 h with 20 mg GST-RalGDS-RBD (for Rap1 analysis) (Franke et al., 1997) or GST-c-Raf-1-RBD (1-149) (for Ras analysis) (Taylor and Shalloway, 1996) . Precipitates were separated by 12% SDS ± PAGE and blotted as indicated.
Immunoprecipitations were carried out using protein ASepharose for polyclonal and protein G-Sepharose for monoclonal antibodies. Cells were lysed in 1% TX buer (20 mM TrisHCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 5% glycerol, 1% Triton X-100) and 1 mg of the lysates were precleared with the beads alone for 1 h. Subsequently, immunoprecipitations were done for 2 h at 48C with the indicated antibodies. Determination of Erk activity was performed by Western blotting of RIPA lysates (20 mM TrisHCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 2 mM EGTA, 5% glycerol, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 200 mg/ml PMSF, 50 mM sodium¯uoride, 1 mM sodium molybdate, 20 mM b-glycerophosphate, 10 mM phenyl phosphate, 16 complete TM protease inhibitors (Roche)) with activation-speci®c phospho-Erk antibodies.
